Brief: Evolent Health Announces Pricing Of Oversubscribed And Upsized $145.0 Million Of Convertible Senior Notes Due 2031 To Repurchase Existing Notes And Class A Common Stock
19/08/2025 12:41
Aug 19 (Reuters) - Evolent Health Inc EVH.N: EVOLENT HEALTH, INC. ANNOUNCES PRICING OF OVERSUBSCRIBED AND UPSIZED $145.0 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2031 TO REPURCHASE EXISTING NOTES AND CLASS A COMMON STOCK Source text: ID:nPn6wwNcFa Further company coverage: EVH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows